Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Suven Pharmaceuticals Ltd - 543064 - General Updates

 With reference to the above subject, the Board of Directors of the company, at its meeting held on August 08, 2022, took note of the letter reference No. SOP-Review-(20-May-2022) received from BSE and NSE/LIST-SOP/COMB/FINES/0823, dated May 20, 2022 received from NSE in the matter of non-compliance identified with respect to Regulation 19 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and given below comments:
09-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Please find attached Investor Presentation
08-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Outcome Of The Board Meeting

 With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. August 08, 2022, has taken on record and approved the Un-Audited Standalone and Consolidated Financial Results prepared under Ind AS along with Limited Review Reports of the Statutory Auditors for the quarter ended 30th June, 2022. We are enclosing herewith the following documents: 1) Un-audited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2022 2) Limited Review Reports on the financial results as mentioned above and 3) A copy of the News Release of our company We request you to take these documents on your records. The Board Meeting commenced at 11:30 A.M. and concluded at 12:45 P.M.
08-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 With reference to above subject, please find enclosed herewith an invitation for conducting the conference call for investors on Monday, August 08, 2022 at 3:30 pm IST to discuss the Un-Audited Financial Results for the Q1 FY23, to be declared on August 08, 2022. This is for your information and record.
04-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Monday, The 8Th August, 2022

 Suven Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Monday, the 8th August, 2022 at 11:30 a.m. at the Registered Office, SDE Serene Chambers, 3rd Floor, Road No 5, Banjara Hills, Hyderabad - 500034 of the Company, to consider, inter alia, and approve the following matter(s): To consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the first quarter ended June 30, 2022. Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from 01st July, 2022 as per PIT Code of the Company. Trading window will be opened from 13th August, 2022.
01-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed News Release of our company in connection with USFDA pre-approval inspection completed at Casper Pharma Private Limited, a wholly owned subsidiary of our Company.
30-07-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In continuation to our letter dated July 26, 2022 regarding Notice of the 4th AGM, please find enclosed the copies of the newspaper advertisements regarding to Notice of the 4th Annual General Meeting of the Company, Book Closure and E-Voting Information. The advertisements as appeared today i.e. July 27, 2022 in Nava Telangana (Telugu) and Business Standard. The above information will also be hosted on the website of the Company at: https://www.suvenpharm.com/index.php/investors/corporate-info/advertisements This is for your information and record.
27-07-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Reg. 34 (1) Annual Report.

 With reference to the above subject, pursuant to Regulation 34 of the SEBI ((Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice convening the 4th AGM of the Members of the Company and the Annual Report for the fiscal 2022 which is simultaneously circulated to the shareholders through electronic mode.
26-07-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Notice Of The Fourth Annual General Meeting (AGM) And Annual Report 2021-22

 With reference to the above subject, pursuant to Regulation 34 of the SEBI ((Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice convening the 4th AGM of the Members of the Company and the Annual Report for the fiscal 2022 which is simultaneously circulated to the shareholders through electronic mode. The 4th AGM will be held on Thursday, August 18, 2022 at 11:30 a.m. IST through Video Conference (VC) / Other Audio Visual Means (OAVM). The Notice and Annual Report will also be hosted on the Company's website at: https://www.suvenpharm.com/index.php/investors/financial-info/annual-reports.
26-07-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisements regarding the 4th Annual General Meeting to be held through Video Conferencing (VC)/ Other Audio Visual Means (OVAM). The advertisements as appeared today i.e. July 21, 2022 in Nava Telangana (Telugu) and Business Standard. The above information will also be hosted on the website of the Company at: https://www.suvenpharm.com/index.php/investors/corporate-info/advertisements This is for your information and record.
21-07-2022
Next Page
Close

Let's Open Free Demat Account